Skip to main
CL

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive (CL) Analyst Ratings

Based on 16 analyst ratings
Buy
Strong Buy 44%
Buy 38%
Hold 19%
Sell 0%
Strong Sell 0%

Bulls say

Colgate-Palmolive is facing some short-term challenges such as slower growth in its core markets and rising input costs. However, its long-term prospects are promising with its global presence, strong brand portfolio, and ongoing cost savings initiatives. With a diverse management team and strong commitments to diversity and inclusion, Colgate-Palmolive is well-positioned to capitalize on growth opportunities. While there are risks such as currency fluctuations and competitive pressures, we believe that Colgate-Palmolive has the potential to consistently deliver strong results and outperform its targets.

Bears say

Colgate-Palmolive is facing a potential decline in organic sales due to the exit of the private label pet food business and uncertain impacts from elevated costs of inputs such as crude oil. Despite its sustainability initiatives, the company's long-term growth prospects may be hindered by these factors and its valuation already appears to be at a premium. Unless Colgate-Palmolive is able to significantly outperform these expectations, its stock price may underperform in the coming years.

Colgate-Palmolive (CL) has been analyzed by 16 analysts, with a consensus rating of Buy. 44% of analysts recommend a Strong Buy, 38% recommend Buy, 19% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Colgate-Palmolive (CL) Forecast

Analysts have given Colgate-Palmolive (CL) a Buy based on their latest research and market trends.

According to 16 analysts, Colgate-Palmolive (CL) has a Buy consensus rating as of Jun 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $95.31, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $95.31, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Colgate-Palmolive (CL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.